Abstract
Abstract
Background
Advances in precision medicine have given oncologists new evaluative tools to better individualize treatments for patients with curable breast cancer. These innovations have revealed a need to improve patient understanding of novel, often complex information related to breast cancer treatment decisions. Ensuring patients have the emotional support to face consequential treatment decisions, as well as the opportunity to engage and discuss with their clinicians, is key to improving patient-centered communication and patient understanding.
Methods/design
This study will implement a multilevel intervention with patient and clinician components as a NCORP Cancer Care Delivery Research (CCDR) trial within the Alliance for Clinical Trials in Oncology Research Base (Alliance). The two interventions in this study, the Shared Decision Engagement System (SharES), include (1) two versions of an evidence-based patient-facing breast cancer treatment decision tool (iCanDecide +/− an emotional support module) and (2) a clinician-facing dashboard (Clinician Dashboard) that is reviewed by surgeons/clinicians and summarizes ongoing patient needs. The design is a near minimax, hybrid stepped wedge trial of SharES where both interventions are being evaluated in a crossed design over six 12-week time periods. The primary outcome (knowledge) and key secondary outcomes (i.e., self-efficacy and cancer worry) are assessed via patient report at 5 weeks after surgery. Secondary outcomes are also assessed at 5 weeks after surgery, as well as in a second survey 9 months after registration. We anticipate recruiting a total of 700 breast cancer patients (600 evaluable after attrition) from 25 surgical practices affiliated with Alliance.
Discussion
Upon study completion, we will have better understanding of the impact of a multilevel intervention on patient-centered communication in breast cancer with a specific focus on whether the intervention components improve knowledge and self-efficacy and reduce cancer worry.
Trial registration
ClinicalTrials.govNCT04549571. Registered on 16 September 2020.
Funder
Division of Cancer Prevention, National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Medicine (miscellaneous)
Reference34 articles.
1. Fagerlin A, Lakhani I, Lantz P, Janz NK, Morrow M, Schwartz K, et al. An informed decision? Breast cancer patients and their knowledge about treatment. Patient Educ Couns. 2006;64(1-3):303–12.
2. You Have the Right to be Hopeful: A publication of the National Coalition for Cancer Survivorship. https://canceradvocacy.org/wp-content/uploads/Hopeful1.pdf (Accessed 8 Dec 2022)
3. Hawley ST, Li Y, An LC, Resnicow K, Janz NK, Sabel MS, et al. Improving breast cancer surgical treatment decision making: the iCanDecide randomized clinical trial. J Clin Oncol. 2018;36(7):659–66.
4. Hawley ST, Janz NK, Hamilton A, Griggs JJ, Alderman A, Mujahid M, et al. Latina patient perspectives about informed treatment decision making for breast cancer. Patient Educ Couns. 2008;73(2):363–70.
5. Hawley ST, Fagerlin A, Janz NK, Katz SJ. Racial/ethnic disparities in knowledge about risks and benefits of breast cancer treatment: does it matter where you go? Health Serv Res. 2008;43(4):1366–76.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献